BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31142407)

  • 1. An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
    Kutlucan A
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):S13-S15. PubMed ID: 31142407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
    Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
    Moulin V; Grandoni F; Castioni J; Lu H
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29903777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine responsive megaloblastic anemia syndrome.
    Ganesh R; Ezhilarasi S; Vasanthi T; Gowrishankar K; Rajajee S
    Indian J Pediatr; 2009 Mar; 76(3):313-4. PubMed ID: 19347672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
    Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
    Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?
    Akın L; Kurtoğlu S; Kendirci M; Akın MA; Karakükçü M
    J Clin Res Pediatr Endocrinol; 2011; 3(1):36-9. PubMed ID: 21448333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
    Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
    BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal diabetes mellitus: remission induced by novel therapy.
    Dalwadi P; Joshi AS; Thakur DS; Bhagwat NM
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
    Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
    Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiamine-responsive megaloblastic anaemia.
    Veetil VM; Pachat D; Nikitha K; Kutty JM
    Natl Med J India; 2023; 36(5):314-315. PubMed ID: 38759983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiamine-responsive megaloblastic anemia syndrome.
    Bay A; Keskin M; Hizli S; Uygun H; Dai A; Gumruk F
    Int J Hematol; 2010 Oct; 92(3):524-6. PubMed ID: 20835854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.
    Setoodeh A; Haghighi A; Saleh-Gohari N; Ellard S; Haghighi A
    Gene; 2013 May; 519(2):295-7. PubMed ID: 23454484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.
    Borgna-Pignatti C; Azzalli M; Pedretti S
    J Pediatr; 2009 Aug; 155(2):295-7. PubMed ID: 19619756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
    Di Candia F; Di Iorio V; Tinto N; Bonfanti R; Iovino C; Rosanio FM; Fedi L; Iafusco F; Arrigoni F; Malesci R; Simonelli F; Rigamonti A; Franzese A; Mozzillo E
    Ital J Pediatr; 2023 Nov; 49(1):158. PubMed ID: 38037112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
    Lu H; Lu H; Vaucher J; Tran C; Vollenweider P; Castioni J
    Rev Med Interne; 2019 Jan; 40(1):20-27. PubMed ID: 30031565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
    Habeb AM; Flanagan SE; Zulali MA; Abdullah MA; Pomahačová R; Boyadzhiev V; Colindres LE; Godoy GV; Vasanthi T; Al Saif R; Setoodeh A; Haghighi A; Haghighi A; Shaalan Y; ; Hattersley AT; Ellard S; De Franco E
    Diabetologia; 2018 May; 61(5):1027-1036. PubMed ID: 29450569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
    Wu S; Yuan Z; Sun Z; Yao F; Sui R
    Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
    Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
    Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
    Yilmaz Agladioglu S; Aycan Z; Bas VN; Peltek Kendirci HN; Onder A
    Genet Couns; 2012; 23(2):149-56. PubMed ID: 22876572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiamine-Responsive Megaloblastic Anaemia With Hypothyroidism, A Puzzling Association.
    Rai VR; Ibrahim MN; Javed MN; Khoso Z; Rathore H
    J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S804-S806. PubMed ID: 38406914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.